Johnson & Johnson was the top innovator in the clinical trial operations sector in the latest quarter. The company filed 31 related patents in the three months ending March. That was up from 11 over the same period in 2021.
It was followed by Roche with 15 patent applications, Bayer (8 applications), and Pfizer (5 applications).
J&J has recently ramped up R&D in . It saw growth of 64.5% in related patent applications in the three months ending March compared to the same period in 2021 - the highest percentage growth out of all companies tracked with more than 10 quarterly patents in the clinical trial operations sector.
Broadly, research and innovation in machine learning in the clinical trial operations sector is on the rise.
The most recent figures show that the number of related patent applications in the industry stood at 75 in the three months ending March - up from 65 over the same period in 2021.
Figures for patent grants related to followed a similar pattern to filings - growing from three in the three months ending March 2021 to seven in the same period in 2022.
The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.
is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.
The figures also provide an insight into the largest innovators in the sector.